Retinoid Metabolism in Hepatitic Stellate Cells

描述（由申请方提供）：本提案的总体目标是了解特定大鼠类维生素A代谢酶（尤其是视黄酯水解酶）在肝星状细胞类维生素A代谢调节中的作用。肝星状细胞是肝脏中维生素A的主要储存库，维生素A主要以棕榈酸视黄酯的形式储存在高度可见的细胞内脂滴中。当动物暴露于肝毒素或人类长期滥用酒精时，星状细胞被激活并转化为肌纤维母细胞样细胞。这些转化细胞是酒精诱导的肝纤维化中胶原和细胞外基质蛋白形成的场所。星状细胞活化的最早期事件之一是视黄酯的水解和细胞内脂滴的消耗。最可能的视黄酯水解酶候选物是广泛底物特异性脂肪酶和羧酸酯酶家族的成员。在肝星状细胞中表达的特异性视黄酯水解酶及其在星状细胞活化过程中的活性调节机制尚不清楚。在初步的数据中，我们发现，五个最常见的大鼠肝脏羧酸酯酶与棕榈酸视黄酯活性在星状细胞中不高表达。然而，对维生素A敏感的脂肪酶基因在大鼠肝星状细胞中表达，并且在体外具有视黄酯棕榈酸水解酶活性。该补助金的目标是通过实时定量RNA PCR和具有酶特异性抗体的星状细胞的免疫荧光显微镜来鉴定在分离的大鼠肝细胞（星状细胞、枯否细胞、肝细胞）中表达的特异性视黄酯水解酶（脂肪酶和羧酸酯酶）。视黄酯水解酶和视黄醇脱氢酶的表达将与脂滴中的类维生素A自发荧光和培养的大鼠星状细胞中细胞特异性标志物的表达相关，因为它们经历成肌纤维细胞样细胞的活化。在可行的情况下，我们将测量棕榈酸视黄酯水解酶活性，并使用酯酶活性染色对细胞提取物进行蛋白质凝胶电泳。我们将研究纯化的大鼠星状细胞视黄酯水解酶的动力学，并研究酶激活剂和抑制剂的作用。星状细胞视黄酯水解抑制剂可能是一种有效的治疗策略，在肝纤维化早期阻止星状细胞活化。

DESCRIPTION (provided by applicant): The overall goal of this proposal is to understand the role of specific rat retinoid metabolizing enzymes (especially retinyl ester hydrolases) in the regulation of retinoid metabolism in hepatic stellate cells. Hepatic stellate cells are the main reservoir of Vitamin A in the liver where it is stored mainly as retinyl palmitate in highly visible intracellular lipid droplets. When animals are exposed to hepatotoxins or humans chronically abuse alcohol, the stellate cells become activated and transform into myofibroblast-like cells. These transformed cells are the sites of collagen and extracellular matrix protein formation in alcohol-induced hepatic fibrosis. One of the earliest events in stellate cell activation is the hydrolysis of retinyl esters and the depletion of the intracellular lipid droplets. The most likely retinyl ester hydrolase candidates are the members of the families of broad substrate specificity lipases and carboxylesterases. The specific retinyl ester hydrolases expressed in hepatic stellate cells and the mechanisms for regulation of their activity during stellate cell activation is not known. In preliminary data, we show that the five most common rat liver carboxylesterases with retinyl palmitate activity are not highly expressed in stellate cells. However, the hormone-sensitive lipase gene is expressed in rat hepatic stellate cells and it has retinyl palmitate hydrolase activity in vitro. The goals of the grant are to identify the specific retinyl ester hydrolases (lipases and carboxylesterases) that are expressed in isolated rat liver cells (stellate cells, Kupffer cells, hepatocytes) by real-time, quantitative PCR of RNA and immunofluorescence microscopy of stellate cells with enzyme-specific antibodies. The expression of retinyl ester hydrolases and retinol dehydrogenases will be correlated with retinoid autofluorescence in lipid droplets and expression of cell-specific markers in cultured rat stellate cells as they undergo activation to myofibroblast-like cells. When feasible, we will measure retinyl palmitate hydrolase activity and perform protein gel electrophoresis of cellular extracts with esterase activity staining. We will examine the kinetics of purified rat stellate cell retinyl ester hydrolases and examine the effects of enzyme activators and inhibitors. Inhibitors of retinyl ester hydrolysis in stellate cells may be an effective therapeutic strategy for arresting stellate cell activation early in hepatic fibrosis.